IPV token, issued by IPXHOP, a subsidiary of IPVERSE LTD, has been listed on the Huobi Global cryptocurrency exchange.
IPVERSE introduced its NFT marketplace called ‘ONFT’, which started with the intellectual property ('IP') market, and yet to add other types of content to the marketplace.
IPXHOP is a global intellectual property (IP) investment platform that allows for the trading of IPs. NHN Bugs has reportedly invested in the company in December 2021.
IPV is a cryptocurrency used in ONFT and also in the IPVERSE ecosystem. IPV is currently listed on several crypto exchanges including Probit Global, XT.COM, and LBANK. IPV is now listed on Huobi Global, the world's sixth largest crypto exchange, according to CoinMarketCap.
Huobi Global has established independent crypto exchanges in different countries and regions, including China, Hong Kong, Japan, Korea and Singapore. Houbi is reportedly preparing to re-enter the U.S. market in 2023.
IPV can be traded at Huobi Global USDT market, and withdrawals was made available from September 17th. The details can be checked on Huobi Global's official website.
The CEO of IPVERSE said, "Huobi Global listing of IPV is the first stepping stone to getting IPV listed on top exchanges and also expanding the project's ecosystem.
This article does not necessarily reflect the opinions of the editors or management of EconoTimes


Ferrari Luce EV Sells for Record $40 Million at Charity Auction
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy
Tesla Roadster Reveal Could Feature SpaceX Thrusters in August
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
China Automakers Accelerate Global Expansion as Domestic Car Sales Slump
Apple Develops China-Specific AI Model With Alibaba as Apple Intelligence Launch Nears
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Stripe, Advent Reportedly Pursue $53 Billion PayPal Takeover
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal 



